Aurorix

moclobemide

A reversible mono-amine oxidase inhibitor (MAOI) used to manage depression and performance anxiety. It is not approved for use in the USA.
 
Adverse effects
Insomnia, headache, dizziness.

Aurorix®

Moclobemide, see there.
Mentioned in ?
References in periodicals archive ?
Its major drugs include Accutane for acne vulgaris, Aurorix for depression, Actemra for rheumatoid arthrritis, Boniva for osteopososis, Cellcept for transplant rejection and Dilatrend for hypertension.
The EUR120m transaction, initially announced in August, covers world-wide rights to Marcoumar, Torem, Tilcotil and Aurorix, which together represent annual sales of some SEK500m.
Top-Selling Antidepressant Pharmaceuticals 1998 Sales in Billions Prozac $2,812.00 Zoloft $1,836.00 Paxil $1,757.00 Effexor $529.00 Wellbutrin $508.79 Serzone $257.00 Remeron $178.45 Aurorix $96.51 Tolvon $71.08 Elen $70.23 Source: MedAd News
Lurasidone * Latuda Mirtazapine * Remeron Moclobemide * Amira, Aurorix, Clobemix, Depnil, Manerix Modafinil * Provigil Olanzapine/fluoxetine * Symbyax Paroxetine * Paxil Phenelzine * Nardil Pramipexole * Mirapex Quetiapine * Seroquel Riluzole * Rilutek Sertraline * Zoloft Vortioxetine * Brintellix